Effects of Perioperative Pregabalin for Post-Craniotomy Pain

Status Withdrawn

Clinical Trial Summary

Objective: To compare the incidence of chronic pain at 3 months among adults undergoing craniotomy between those received two different doses of pregabalin and those receiving placebo.

Clinical Trial Description

Hypothesis: Perioperative pregabalin will reduce the incidence of chronic post-operative pain, and will reduce the opioid consumption, opioid-related side effects, and hospital length of stay compared with placebo in patients undergoing elective craniotomy.

Methods: 316 adults (18-65y), ASA I-III, undergoing elective craniotomy will be randomized to receive: 100mg or 150mg pregabalin or placebo once pre-operatively and 50mg or 75mg or placebo twice daily for 14 post-operative days. NRS pain scores, opioid consumption and side effects will be assessed up to 48h, and long-term pain at days 7, 14, 30, and 90. The primary analysis will involve the comparison between the 2 treatment groups together vs. placebo. A stepwise method will be used to evaluate the pairwise comparisons.

Outcomes: The primary outcome will be the incidence of chronic post-craniotomy pain at 3 mos. Important secondary outcomes are: neuropathic component of pain at 3 mos., total opioid consumption in the first 24h, and incidence and severity of opioid-related side effects at days 1, 2 and 7. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01591980
Study type	Interventional
Source	St. Michael's Hospital, Toronto
Contact
Status	Withdrawn
Phase	Phase 4
Start date	August 2013
Completion date	August 2014

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03472872` - A Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache	Phase 4
Withdrawn	`NCT05410366` - Safe Harbors in Emergency Medicine, Specific Aim 3
Withdrawn	`NCT02866084` - Neuromodulation Treatment of Vestibular Migraines	N/A
Active, not recruiting	`NCT03537573` - Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care	N/A
Recruiting	`NCT05891808` - miR-155 Expression in Episodic and Chronic Migraine
Not yet recruiting	`NCT04352218` - Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache	Phase 2
Completed	`NCT02734992` - Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers	N/A
Completed	`NCT01327118` - Prostaglandin F2alpha in a Human Headache Model	N/A
Completed	`NCT01153789` - Study of Oculomotor Dysfunction Leading to Children Vertigo	N/A
Not yet recruiting	`NCT00969995` - Identification of Inflammatory Markers in Migraine Patients	N/A
Not yet recruiting	`NCT00752921` - Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache	Phase 4
Completed	`NCT00212810` - Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.	Phase 4
Terminated	`NCT00291395` - PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers	Phase 1
Completed	`NCT00263094` - An End to the Yom Kippur (and Ramadan) Headache	N/A
Completed	`NCT00135122` - Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache	Phase 3
Completed	`NCT02475005` - An Intervention to Improve Adolescent Headache Self-management	N/A
Completed	`NCT03163901` - The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury	N/A
Completed	`NCT01664585` - Exercise Training With Physically Active Lifestyle to Reduce Headache and Quality of Life	N/A
Completed	`NCT04632420` - Evaluation of Headache and Childbirth in a Chronic Pain Population
Recruiting	`NCT05033613` - Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease